Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Safety and Aesthetic Outcomes of a Novel Endoscopic-Assisted Breast-Conserving Surgery (SRRSHzb-EABCS) With Those of Conventional Breast-Conserving Surgery

NCT07920094 is registered in ClinicalTrials.gov with Sir Run Run Shaw Hospital as lead sponsor.

NCT NCT07920094 Recruiting Not applicable 422 participants (estimated) Started 2023 22 sites

Follow this trial by email Email me the PDF

Get the NCT07920094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Recruiting, started July 2023. Interventional study, 422 participants (estimated). Lead sponsor Sir Run Run Shaw Hospital; China. Primary measure: Intraoperative and Postoperative Positive Margin Rate. 3 linked papers (newest 2021).

How it compares

4,055 similar trials: same condition (Breast Neoplasms) and phase

Enrollment

This trial
422
Middle half
36 to 198
Median
80
Trials with a value
4,029

Months from start to completion

This trial
126
Middle half
17.1 to 59.6
Median
33.2
Trials with a value
3,988

Sites

This trial
22
Middle half
1 to 1
Median
1
Trials with a value
3,752
Posted results or a linked paper 44% 1,795 of 4,055 similar trials; this trial: yes

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Safety and Aesthetic Outcomes of a Novel Endoscopic-Assisted Breast-Conserving Surgery (SRRSHzb-EABCS) With Those of Conventional Breast-Conserving Surgery
Lead sponsor
Sir Run Run Shaw Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2023
Completion date
December 31, 2033
Enrollment
422 (estimated)
Sites
22

Conditions

MeSH condition names; the registry's own terms follow.

Breast Neoplasms

Registry terms: breast cancer

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
Female
Minimum age
18 Years
Maximum age
70 Years
Healthy volunteers
No
Study type
Interventional
Sites
22
Countries
China
Lead sponsor
Sir Run Run Shaw Hospital

Arms

As registered; 2 arms.

Registered arms
Arm Type Interventions
SRRSHzb-EABCS group Experimental Endoscopy-assisted breast-conserving surgery (SRRSHzb-EABCS)
Show registry wording

Participants undergo the novel endoscopy-assisted breast-conserving surgery SRRSHzb-EABCS, which uses a gasless expansion-traction endoscopic system with two custom-built instruments (a skin flap dissector and a V-shaped retractor) and percutaneously placed U-shaped metal wires for tumor localization and margin control. Through a single 3.0-4.5 cm axillary incision, the retromammary space and subcutaneous flap are created, and each U-shaped cutting wire is connected to an electrocautery pencil and energized to cut precisely along the planned resection margin under endoscopic vision ("hot-wire" cutting). Specimen margins are assessed by intraoperative frozen section; if a margin is positive, local re-excision of the margin is performed, and if margins remain repeatedly positive, mastectomy is performed. The defect is reconstructed with a pedicled glandular flap using volume displacement oncoplastic technique.

Conventional breast-conserving surgery (CBCS) group Active comparator Conventional open breast-conserving surgery (CBCS)
Show registry wording

Participants undergo conventional open breast-conserving surgery performed according to the Chinese Anti-Cancer Association guidelines for breast-conserving therapy, generally through separate breast and axillary incisions. The resection includes the tumor with surrounding breast tissue; specimen margins are marked and assessed (margin inking and/or intraoperative frozen section and imprint cytology); 4-6 titanium clips are placed in the tumor bed; and oncoplastic volume displacement or replacement techniques are used when needed. If a margin is positive on intraoperative or postoperative pathology, local re-excision of the margin is performed, and if margins remain repeatedly positive, mastectomy is performed.

Primary endpoints

Registered primary outcome measures; 1 primary.

Registered primary endpoints
Measure Time frame
Intraoperative and Postoperative Positive Margin Rate Intraoperatively and up to 1 month after surgery (final pathology report)
Show registry wording

Proportion of participants with positive resection margins of the breast-conserving specimen, including the first and any subsequent positive margins on intraoperative frozen section assessment and the positive margin rate on postoperative routine paraffin pathology.

Papers

PubMed papers this trial cites; 3 papers, results papers first, then newest first.

Source: PubMed, NCBI/NLM (public domain).

Lead sponsor's other trials

Sir Run Run Shaw Hospital, most recent start first.

Similar trials

Same condition (Breast Neoplasms) and phase, most recent start first.